Aquestive Therapeutics Inc (AQST) — Capital Reinvestment Ratio
Aquestive Therapeutics Inc (AQST) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($8.82 Million) in capital expenditures ($2.00K). See net asset quality index of Aquestive Therapeutics Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aquestive Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Aquestive Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Aquestive Therapeutics Inc (AQST) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Aquestive Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Aquestive Therapeutics Inc from 2017 to 2017. For live market cap and broader valuation context, see market cap of Aquestive Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.36x | $5.82 Million | $2.07 Million | — |